share_log
Reuters ·  05/03 16:08

Brainstorm Cell Therapeutics: Received Letter From Nasdaq Indicating Co Had Not Regained Compliance With Minimum Bid Price Requirement by April 29

Brainstorm Cell Therapeutics:收到纳斯达克的来信,表明截至4月29日,该公司尚未恢复遵守最低出价要求

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发